Packaging and Distribution

The added capabilities include clinical-scale sachet and blister packaging for clinical trial pharmaceuticals and a relationship with a European Union Qualified Person for its CTS offerings.

Contract packaging organizations packaging biologic drugs for clinical trials use technologies that meet the unique requirements of each study.

Supply-chain visibility systems are proving their worth in the distribution of COVID-19 vaccines and may see broader use in the future.

Blow-fill-seal (BFS) technology presents an economical option for single-unit dose delivery of vaccines.

Complex formulations, personalized medicines, COVID-19 therapies, and sustainability goals are driving innovations in drug packaging.

CalAmp's new sensor for cold-chain applications provides visibility for shipping vaccines.

Material properties play a role in container closure integrity under frozen or cryogenic storage temperatures.

Drug product security requires anti-counterfeiting techniques such as authentication throughout the supply chain.

Dosage-level authentication provides an added digital layer of security for pharmaceutical companies to ensure their products are not exposed to falsification.

The partnership will combine Cold Chain Technologies thermal packaging with B Medical Systems’ stationary refrigeration solutions for temperature-critical pharmaceuticals.

Under an expanded agreement with J&J, Catalent Biologics will increase manufacturing capacity at its Anagni, Italy, site to accommodate the large-scale commercial supply of Janssen’s COVID-19 vaccine.

Smart packaging opens doors to new products for diagnosis and treatment of eye problems.

TurboFil’s CrimpTech Series includes semi- and fully automatic machines.

Manufacturing of the vaccine will take place at Baxter’s fill/finish sterile manufacturing facilities located in Bloomington, IN.

Labeling, printing, and on-dose tagging technologies provide a multi-layered approach to anticounterfeiting for pharmaceuticals.

The study found that more than 90% of packages and cases scanned at three companies met all of the labeling requirements, with three years remaining until the final DSCSA deadline in 2023.

Anticounterfeiting technology protects the supply chain from manufacturer to patient.

Packaging and transporting large quantities of COVID-19 vaccines pose challenges for the cold chain.

Acorda’s Chelsea, MA facility will serve as a global center of excellence in the Catalent network for spray-dried dispersion and dry powder encapsulation and packaging.

The films are now available in three options of varying thickness for added protection against moisture and oxygen.

Due to a packaging error, the company is voluntarily recalling one lot of sildenafil 100 mg tablets for the treatment of erectile dysfunction and one lot of trazodone 100mg tablets for the treatment of major depressive disorder.

Freezers, shipping containers, and tracking systems aid distribution of COVID-19 vaccines.

Flexible packaging benefits align with challenges including an aging population, compliance requirements, e-commerce, serialization, and a need for recyclability.

Software automates the labeling process, ensures compliance with regulations, prevents errors, and cuts costs.

Through the acquisition, PTI will gain access to LDA’s lead product, the SIMS 1915+, a helium leak test system that combines its helium leak detection technology with its SIMS software for data collection and analysis.

Sterilization of primary packaging is important for vaccines.

Packaging suppliers prepare to meet the demand unleashed by COVID-19 vaccines and treatments.

Eisai has announced an expansion of its manufacturing operations at its Hatfield production plant in the United Kingdom to meet global demand.

Experts fear confusion over allocation processes, cold-chain requirements, and IT systems needed to bring a COVID-19 vaccine to market.

The companies will work together to produce a wearable device that can subcutaneously deliver ketamine therapy as a non-opioid pain treatment.